Xtant Medical makes bone graft materials and spinal implant systems for spine surgeons and hospitals. It last closed at $0.21 on Nov 20, down 2.82% on the day. The next earnings report for XTNT is expected around Tue, Mar 30, 2027. For the quarter ended Sep 2026, XTNT reported EPS of -$0.03 on revenue of $24.3M, with revenue down 27.0% from a year ago. Over its last 8 reports the stock moved an average of 11.4% the session after earnings.
AI Auto Pilots
Is XTNT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold XTNT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on XTNTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
XTNT · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 26% below its 20 day and 44% below its 50 day average. It is 107% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 27), oversold. The nearest support is the Pivot S1 at $0.19, and the nearest resistance the Pivot at $0.22.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 14.6%/day
Key levels
$0.8452 week high+300.0%
$0.43200 day average+104.8%
$0.35100 day average+66.7%
$0.31Swing high (Nov 13)+47.6%
$0.3050 day average+42.9%
$0.2620 day average+23.8%
$0.24Pivot R1+14.3%
$0.22Pivot+4.8%
$0.21Last close
$0.19Pivot S1−9.5%
$0.1752 week low−19.0%
$0.17Swing low (Nov 16)−19.0%
Indicators
RSI (14)
27.20
Oversold below 30
Oversold
MACD
-0.03
Below its signal line
Bearish
Stochastic
25.9
Middle of its range
Neutral
ADX (14)
19.5
No clear trend
Williams %R
-73.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-116.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−27.4%
Change over 10 sessions
Bearish
ATR (14)
$0.03
Typical daily range, 14.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 32.7%/day
Key levels
$0.8452 week high+300.0%
$0.43200 day average+104.8%
$0.35100 day average+66.7%
$0.31Swing high (Nov 13)+47.6%
$0.3050 day average+42.9%
$0.2620 day average+23.8%
$0.24Pivot R1+14.3%
$0.22Pivot+4.8%
$0.21Last close
$0.19Pivot S1−9.5%
$0.1752 week low−19.0%
$0.17Swing low (Nov 16)−19.0%
Indicators
RSI (14)
28.45
Oversold below 30
Oversold
MACD
-0.06
Below its signal line
Bearish
Stochastic
8.9
Near the bottom of its range
Oversold
ADX (14)
22.6
Weak trend
Williams %R
-87.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-186.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−39.3%
Change over 10 sessions
Bearish
ATR (14)
$0.07
Typical daily range, 32.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for XTNT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how XTNT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow XTNT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for XTNTHow many large options trades hit XTNT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in XTNT in the last 90 days.
From SEC Form 4 filings by XTNT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether XTNT is in one of them and how their past XTNT trades turned out.
Xtant Medical makes orthobiologics, which are bone graft materials, along with spinal implant fixation systems used in spinal fusion surgery. Its products include human bone allografts, synthetic bone graft substitutes, and amniotic membrane allografts for wound care. Orthopedic spine surgeons and neurosurgeons are the main users, and the company sells mostly in the United States through independent agents and distributors, with some sales in Europe, Canada, Mexico, South America, and parts of the Pacific region. The company is based in Belgrade, Montana.